SIRPA and neoplasm: To boost antitumor immunity, cell membranes are often engineered to constitutively express stimulatory cues (e.g., ovalbumin, CD80 and SIRPa) for antigen-presenting cells (APCs) and tumor-associated macrophages (TAMs).